CoChat

Dipeptidyl peptidase IV (DDP IV) in NASH patients

Open access
Balaban, Yasemin H., Korkusuz, Petek, Simsek, Halis, Gokcan, Hale, Gedikoglu, Gokhan, Pinar, Asli, Hascelik, Gulsen, Asan, Esin, Hamaloglu, Erhan, Tatar, Gonca · 2007 · Annals of Hepatology

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

OBJECTIVE(S): Non-alcoholic steatohepatitis (NASH) is a chronic liver disease with unknown etiology. The insulin resistance, immune mechanisms and oxidative stress are the main factors in its pathogenesis. Dipeptidyl peptidase IV (DPPIV) or CD26 is a protein with endocrine and immune functions. This study aimed to elicudate the changes related to DPPIV in NASH patients. METHODS: Serum and urinary DPPIV activities were measured in 31 NASH patients and 17 healthy controls. The liver biopsies of 29 patients were immunolabeled for CD26. RESULTS: The mean age of patients were 46 +/- 11 years and 14 (45%) of them were female. The serum DPPIV activity was higher in patients (57.3 +/- 7.8 U/L) than controls (43.6 +/- 10.6 U/L) (p < 0.0001), and correlated with the histopathological grade (p = 0.038, r = 0.373) and hepatosteatosis (p = 0.018, r = 0.423) but not with stage (p = 0.286), class (p = 0.286) or CD26 staining (p = 0.743). The urinary DPPIV activity was similar in patients (1.52 +/- 0.94 U/mmol creatinine) and controls (1.37 +/- 0.68 U/mmol creatinine) (p = 0.861). Three acinar zones of liver had equal CD26 expression (p = 0.076). The intensity of CD26 immunostaining was correlated with histopathological grade (p = 0.001) and hepatosteatosis (p = 0.003) but no correlation with stage or class could be detected (p = 0.610 and 0.956, respectively). In CONCLUSIONS: The serum DPPIV activity and the staining intensity of CD26 in liver are correlated with histopathologic grade of NASH and hepatosteatosis. DPPIV can be proposed as a novel candidate with several potential functions in NASH pathogenesis.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1665-2681(19)31905-2

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Cited by

See all 128

Metadata

Authors
Balaban, Y. H., Korkusuz, P., Simsek, H., Gokcan, H., Gedikoglu, G., Pinar, A., Hascelik, G., Asan, E., Hamaloglu, E., & Tatar, G.
Affiliations
  • Bolu Abant İzzet Baysal University (TR)
  • Hacettepe University (TR)
Corresponding author
Balaban, Yasemin H.
Venue
Annals of Hepatology
Publisher
Elsevier BV
Published
2007-10
Volume
6
Issue
4
Pages
242-250
ISSN
1665-2681 (ISSN-L)
OpenAlex
W2102131917
Cited by
125
References
36
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 8 · 2021: 11 · 2020: 12 · 2019: 4 · 2018: 11 · 2017: 13 · 2016: 13 · 2015: 8 · 2014: 9 · 2013: 9 · 2012: 3
FWCI
0.69
Type
journal article
Language
en
Open access
Licence
Locations
  • Annals of Hepatology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
Funders
  • Hacettepe Üniversitesi
  • United European Gastroenterology
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
dipeptidyl peptidase IV, CD26, nonalcoholic steatohepatitis, hepatic steatosis, NASH pathogenesis
MeSH terms
Adult, Fatty Liver, Female, Hepatitis, Humans, Liver, Male, Middle Aged, Dipeptidyl Peptidase 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dipeptidyl peptidase IV (DDP IV) in NASH patients. https://app.cochat.ai/papers/10.1016/s1665-2681(19)31905-2
The paper
Balaban, Y. H., Korkusuz, P., Simsek, H., Gokcan, H., Gedikoglu, G., Pinar, A., Hascelik, G., Asan, E., Hamaloglu, E., & Tatar, G. (2007). Dipeptidyl peptidase IV (DDP IV) in NASH patients. Annals of Hepatology. https://doi.org/10.1016/s1665-2681(19)31905-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.